Physician profile
Darin Thomas Smith
NPI 1538375415
$3,804.00
in general payments reported to CMS, 2019-2025
21 companies · $526 in 2025
The $526 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $639 · 2022: $953 · 2023: $842 · 2024: $844 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,993 · Education: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,993.41 |
| Education | $218.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,522.30 | 2021-2025 | |
| Janssen Biotech, INC. | $386.23 | 2023-2025 | Tremfya, Simponi, Stelara |
| Leo Pharma INC. | $323.96 | 2021-2024 | Adbry |
| Dermavant Sciences, INC. | $251.87 | 2023-2024 | Vtama |
| Ucb, INC. | $212.26 | 2022-2024 | Bimzelx |
| Pfizer INC. | $206.63 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $169.89 | 2021-2025 | Dupixent, Libtayo |
| Journey Medical Corporation | $162.75 | 2021-2022 | |
| Galderma Laboratories, L.P. | $151.67 | 2021-2024 | |
| Biofrontera INC. | $88.33 | 2022-2025 | |
| Lilly USA, LLC | $49.01 | 2023-2025 | Ebglyss, Taltz, Olumiant |
| Amgen INC. | $48.69 | 2021-2024 | Otezla |
| Arcutis Biotherapeutics, INC. | $46.52 | 2023 | |
| Organon LLC | $37.11 | 2025 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $31.74 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $21.31 | 2022 | |
| Sun Pharmaceutical Industries INC. | $20.65 | 2024 | |
| Krystal Biotech INC | $20.59 | 2023 | Vyjuvek |
| Incyte Corporation | $20.37 | 2022 | |
| Mimedx Group, INC. | $17.19 | 2024 | |
| Vyne Pharmaceuticals INC. | $14.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.